Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1982 1
1983 1
1984 1
1990 1
1993 1
1994 1
1996 1
1997 2
1998 1
1999 1
2000 2
2001 1
2003 1
2004 2
2005 1
2006 2
2007 3
2008 3
2009 5
2010 3
2011 3
2012 2
2013 1
2014 4
2015 5
2016 4
2017 5
2018 10
2019 13
2020 17
2021 24
2022 25
2023 19
2024 25
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Reliability of human cortical organoid generation.
Yoon SJ, Elahi LS, Pașca AM, Marton RM, Gordon A, Revah O, Miura Y, Walczak EM, Holdgate GM, Fan HC, Huguenard JR, Geschwind DH, Pașca SP. Yoon SJ, et al. Nat Methods. 2019 Jan;16(1):75-78. doi: 10.1038/s41592-018-0255-0. Epub 2018 Dec 20. Nat Methods. 2019. PMID: 30573846 Free PMC article.
Cerebrospinal fluid immune dysregulation during healthy brain aging and cognitive impairment.
Piehl N, van Olst L, Ramakrishnan A, Teregulova V, Simonton B, Zhang Z, Tapp E, Channappa D, Oh H, Losada PM, Rutledge J, Trelle AN, Mormino EC, Elahi F, Galasko DR, Henderson VW, Wagner AD, Wyss-Coray T, Gate D. Piehl N, et al. Cell. 2022 Dec 22;185(26):5028-5039.e13. doi: 10.1016/j.cell.2022.11.019. Epub 2022 Dec 13. Cell. 2022. PMID: 36516855 Free PMC article.
Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease.
Gate D, Saligrama N, Leventhal O, Yang AC, Unger MS, Middeldorp J, Chen K, Lehallier B, Channappa D, De Los Santos MB, McBride A, Pluvinage J, Elahi F, Tam GK, Kim Y, Greicius M, Wagner AD, Aigner L, Galasko DR, Davis MM, Wyss-Coray T. Gate D, et al. Nature. 2020 Jan;577(7790):399-404. doi: 10.1038/s41586-019-1895-7. Epub 2020 Jan 8. Nature. 2020. PMID: 31915375 Free PMC article.
Inducible HEK293 AAV packaging cell lines expressing Rep proteins.
Jalšić L, Lytvyn V, Elahi SM, Hrapovic S, Nassoury N, Chahal PS, Gaillet B, Gilbert R. Jalšić L, et al. Mol Ther Methods Clin Dev. 2023 Jul 15;30:259-275. doi: 10.1016/j.omtm.2023.07.002. eCollection 2023 Sep 14. Mol Ther Methods Clin Dev. 2023. PMID: 37560197 Free PMC article.
The use of oral and enteral tube-fed arginine supplementation in pressure injury care: A systematic review and meta-analysis.
Cheshmeh S, Hojati N, Mohammadi A, Rahmani N, Moradi S, Pasdar Y, Elahi N. Cheshmeh S, et al. Nurs Open. 2022 Nov;9(6):2552-2561. doi: 10.1002/nop2.974. Epub 2021 Jun 25. Nurs Open. 2022. PMID: 34170617 Free PMC article. Review.
Subgroup analysis showed that administering Arginine supplement more than 15 g/day had more beneficial effects on the healing of PIs (SMD: -2.8; CI 95%: -4.08 to -1.52, I(2) : 54.7%, p = .138). ...
Subgroup analysis showed that administering Arginine supplement more than 15 g/day had more beneficial effects on the healing of PIs …
Chimeric Antigen Receptor (CAR)-Based Cell Therapy for Type 1 Diabetes Mellitus (T1DM); Current Progress and Future Approaches.
Mohammadi V, Maleki AJ, Nazari M, Siahmansouri A, Moradi A, Elahi R, Esmaeilzadeh A. Mohammadi V, et al. Stem Cell Rev Rep. 2024 Apr;20(3):585-600. doi: 10.1007/s12015-023-10668-1. Epub 2023 Dec 28. Stem Cell Rev Rep. 2024. PMID: 38153634 Review.
Different immune-modulatory therapies could be used, e.g., monoclonal-based immunotherapy, mesenchymal stem cell, and immune cell therapy. ...
Different immune-modulatory therapies could be used, e.g., monoclonal-based immunotherapy, mesenchymal stem cell, and immune cell the …
Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome.
Saito S, Shahbaz S, Luo X, Osman M, Redmond D, Cohen Tervaert JW, Li L, Elahi S. Saito S, et al. Front Immunol. 2024 Jan 18;15:1341843. doi: 10.3389/fimmu.2024.1341843. eCollection 2024. Front Immunol. 2024. PMID: 38304426 Free PMC article.
Moreover, we observed a significant elevation in the plasma pro-inflammatory biomarkers (e.g. IL-1alpha, IL-6, TNF-alpha, Flt-1, and sCD14) but the reduction in ATP in LC patients. ...
Moreover, we observed a significant elevation in the plasma pro-inflammatory biomarkers (e.g. IL-1alpha, IL-6, TNF-alpha, Flt-1, and …
Hematopoietic responses to SARS-CoV-2 infection.
Elahi S. Elahi S. Cell Mol Life Sci. 2022 Mar 13;79(3):187. doi: 10.1007/s00018-022-04220-6. Cell Mol Life Sci. 2022. PMID: 35284964 Free PMC article. Review.
A wide spectrum of microbial agents/products and the consequences of infection-induced mediators (e.g. cytokines, chemokines, and growth factors) can have prominent impact on HSPCs. While COVID-19 starts as a respiratory tract infection, it is considered a systemic disease …
A wide spectrum of microbial agents/products and the consequences of infection-induced mediators (e.g. cytokines, chemokines, and gro …
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
170 results